E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

Target Protein

DFBPID TPFIBR0038
ProteinName Fibrinogen beta chain
Function

Cleaved by the protease thrombin to yield monomers which, together with fibrinogen alpha (FGA) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the antibacterial immune response via both innate and T-cell mediated pathways.

TargetGene
Specific Target Gene
Target protein:
Recommended name:
     • Fibrinogen beta chain
Cleaved into the following 2 chains:
     • Fibrinopeptide B
     • Fibrinogen beta chain
Target gene ID:
FGB
Organism of Target:
Homo sapiens (Human)
Taxonomic identifier:
9606  [NCBI]
Target Uniprot ID:P02675
Target ChEMBL ID:
CHEMBL2048
Target TTD ID:No data
Diseases
Diseases associated with this peptide
Congenital afibrinogenemia (CAFBN)See also OMIM:202400
Dysfibrinogenemia, congenital (DYSFIBRIN)See also OMIM:616004
Pathways
Enzyme and pathway databases of target protein
ReactomeR-HSA-114608 Platelet degranulation
R-HSA-140875 Common Pathway of Fibrin Clot Formation
R-HSA-216083 Integrin cell surface interactions
R-HSA-354192 Integrin alphaIIb beta3 signaling
R-HSA-354194 GRB2:SOS provides linkage to MAPK signaling for Integrins
R-HSA-372708 p130Cas linkage to MAPK signaling for integrins
R-HSA-5674135 MAP2K and MAPK activation
R-HSA-5686938 Regulation of TLR by endogenous ligand
R-HSA-6802946 Signaling by moderate kinase activity BRAF mutants
R-HSA-6802948 Signaling by high-kinase activity BRAF mutants
R-HSA-6802949 Signaling by RAS mutants
R-HSA-6802952 Signaling by BRAF and RAF fusions
R-HSA-6802955 Paradoxical activation of RAF signaling by kinase inactive BRAF
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214